Andrew J Stephenson

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. pmc Management of poor-prognosis testicular germ cell tumors
    Kiranpreet Khurana
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH Department of Solid Tumor Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA
    Indian J Urol 26:108-14. 2010
  2. doi request reprint Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA Electronic address
    Eur Urol 65:675-80. 2014
  3. doi request reprint Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Eur Urol 61:443-51. 2012
  4. pmc Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    J Clin Oncol 25:2035-41. 2007
  5. doi request reprint Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Urol 182:1357-63. 2009
  6. doi request reprint Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
    Andrew J Stephenson
    Section of Urologic Oncology, Glickman Urological and Kidney Institute, Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195 0001, USA corrected
    Eur Urol 55:610-6. 2009
  7. doi request reprint Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomes
    Andrew J Stephenson
    Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
    BJU Int 102:1296-301. 2008
  8. doi request reprint Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009
    Andrew J Stephenson
    Department of Urologic Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 78:S444-55. 2011
  9. doi request reprint Current treatment options for clinical stage I seminoma
    Andrew J Stephenson
    Center for Urology Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
    World J Urol 27:427-32. 2009
  10. doi request reprint Surgical management of low-stage nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
    BJU Int 104:1362-8. 2009

Detail Information

Publications74

  1. pmc Management of poor-prognosis testicular germ cell tumors
    Kiranpreet Khurana
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH Department of Solid Tumor Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA
    Indian J Urol 26:108-14. 2010
    ..A complete surgical resection of all residual sites of disease after chemotherapy is critical for the prevention of relapse and the long-term survival of patients with advanced germ cell tumors...
  2. doi request reprint Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA Electronic address
    Eur Urol 65:675-80. 2014
    ..However, the association between PSMs and prostate cancer-specific mortality (CSM) is poorly defined...
  3. doi request reprint Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Eur Urol 61:443-51. 2012
    ....
  4. pmc Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    J Clin Oncol 25:2035-41. 2007
    ..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
  5. doi request reprint Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Urol 182:1357-63. 2009
    ..In a multicenter study we analyzed the predictive usefulness of several subclassifications of positive surgical margins...
  6. doi request reprint Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
    Andrew J Stephenson
    Section of Urologic Oncology, Glickman Urological and Kidney Institute, Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195 0001, USA corrected
    Eur Urol 55:610-6. 2009
    ..5 ng/ml) given the 17% prostate cancer (pCA) detection rate at PSA of 1.1-2.0. The outcome of patients treated at PSA < or = 2.5 is poorly defined, and advantages associated with such an early diagnosis are uncertain...
  7. doi request reprint Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomes
    Andrew J Stephenson
    Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
    BJU Int 102:1296-301. 2008
    ..Randomized trials are necessary to determine if the results achieved with LRC are equivalent to those of ORC...
  8. doi request reprint Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009
    Andrew J Stephenson
    Department of Urologic Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 78:S444-55. 2011
    ..To advise urologists and other clinicians on the appropriate management of low-stage (clinical Stage [CS] I, IS, IIA, and IIB) nonseminomatous germ cell tumors of the testis...
  9. doi request reprint Current treatment options for clinical stage I seminoma
    Andrew J Stephenson
    Center for Urology Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
    World J Urol 27:427-32. 2009
    ..Adjuvant dog-leg radiotherapy is the preferred approach for non-compliant patients or those unwilling to go on surveillance...
  10. doi request reprint Surgical management of low-stage nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
    BJU Int 104:1362-8. 2009
    ..The therapeutic efficacy of laparoscopic RPLND is not proven and currently should be considered a staging procedure only. Adjuvant chemotherapy after RPLND is typically restricted to patients with pathological stage N2-3 disease...
  11. doi request reprint Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis
    Carvell T Nguyen
    Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Desk Q10, Cleveland OH, 44195 0001, USA
    J Clin Oncol 28:119-25. 2010
    ..Surveillance was the preferred intervention for all except those patients at high risk for relapse...
  12. doi request reprint Chemoprevention of prostate cancer
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk Q10 1, Cleveland, OH 44195 0001, USA
    Urol Clin North Am 37:11-21, Table of Contents. 2010
    ..5alpha-reductase inhibitors represent an effective primary prevention strategy, and these agents should be used more liberally for the prevention of prostate cancer, particularly in high-risk patients...
  13. doi request reprint Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series
    Christopher J Weight
    Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195 0001, USA
    Cancer 115:792-9. 2009
    ..The outcome of NC and open radical cystectomy (RC) was evaluated in a contemporary cohort of patients in a tertiary referral setting...
  14. doi request reprint Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy
    Brian R Lane
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    Cancer 116:2967-73. 2010
    ..Although multimodal treatment paradigms for UTUC are under-developed, this has important implications on patients' ability to receive cisplatin-based combination chemotherapy (CBCC)...
  15. pmc Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Natl Cancer Inst 98:715-7. 2006
    ..Thus, a new preoperative nomogram provides robust predictions of prostate cancer recurrence up to 10 years after radical prostatectomy...
  16. ncbi request reprint Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 174:557-60; discussion 560. 2005
    ....
  17. doi request reprint Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder
    Islam A Ghoneim
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Urology 77:867-70. 2011
    ..Radical cystectomy is considered the standard approach for treatment of patients with localized disease; however, the role of perioperative systemic therapy has been poorly defined...
  18. ncbi request reprint Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 25:5597-602. 2007
    ..3). CONCLUSION Patient selection factors have significantly improved the outcome of patients with CS IIA and IIB NSGCT without substantially increasing the proportion of patients exposed to chemotherapy...
  19. pmc Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 23:7005-12. 2005
    ..We have updated the nomogram by extending the predictions to 10 years after RP and have enabled the nomogram predictions to be adjusted for the disease-free interval that a patient has maintained after RP...
  20. doi request reprint Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer
    Rahul D Tendulkar
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Int J Radiat Oncol Biol Phys 87:94-9. 2013
    ..We aim to identify the causes of death and factors predictive for mortality in this population...
  21. ncbi request reprint Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy
    Fernando J Bianco
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:448-53. 2005
    ..We report the long-term cancer control associated with salvage RP in a consecutive cohort of patients and identify the variables associated with disease progression and cancer survival...
  22. ncbi request reprint Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
    Andrew J Stephenson
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:3973-8. 2006
    ..Ten definitions of BCR were evaluated to identify the one that best explains metastatic progression...
  23. doi request reprint Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management
    Armine K Smith
    Glickman Urological and Kidney Institute, Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
    Urology 78:82-6. 2011
    ..However, concerns about potential understaging, inaccurate grading, incomplete resection, lack of effective tertiary chemoprevention, and need for ureteroscopic surveillance limits it appeal...
  24. doi request reprint The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival
    Carvell T Nguyen
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Urol 181:75-80. 2009
    ..Various schemes based on clincopathological criteria have been proposed to stratify cases by presumed recurrence risk. We determined whether survival outcomes are dependent on the specific definition...
  25. doi request reprint Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study
    Ranko Miocinovic
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195 0001, USA
    J Urol 186:1269-73. 2011
    ..We evaluated the incidence of positive lymph nodes in the presacral and retroperitoneal regions in patients who underwent radical cystectomy and extended pelvic lymph node dissection for urothelial bladder cancer...
  26. pmc Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era
    Andrew J Stephenson
    Glickman Urological and Kidney Institute and Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA
    J Clin Oncol 27:4300-5. 2009
    ..Models that predict the risk of PCSM are needed for patient counseling and clinical trial design...
  27. doi request reprint The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy
    Michael C Lee
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    Eur Urol 58:90-5. 2010
    ..Few reports attempt to validate the role of Epstein criteria in selecting patients for an active surveillance protocol...
  28. doi request reprint A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer
    Edouard J Trabulsi
    Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Urology 72:1298-302; discussion 1302-4. 2008
    ..We studied a group of patients undergoing ART by comparing them with a matched control group undergoing SRT after biochemical failure...
  29. doi request reprint Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer
    Vairavan S Subramanian
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Urol Oncol 28:504-9. 2010
    ..We sought to compare the complication profile of primary (P-) and post-chemotherapy (PC-) RPLND using a standardized complication grading scale...
  30. ncbi request reprint Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 94:1210-2. 2004
  31. ncbi request reprint Nomograms for prostate cancer
    Andrew J Stephenson
    Section of Urologic Oncology, Glickman Urological Institute, Lerner College of Medicine, Cleveland, OH, USA
    BJU Int 98:39-46. 2006
  32. doi request reprint Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria
    Ranko Miocinovic
    Glickman Urololgical and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Urology 77:980-4. 2011
    ..To analyze the acceptance rate and durability of surveillance among contemporary men with low-risk prostate cancer managed at a large, US academic institution...
  33. doi request reprint Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatment
    Ranko Miocinovic
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 77:946-50. 2011
    ..To examine the ability of surgery as initial management in avoiding androgen deprivation therapy (ADT) in patients with high-risk localized prostate cancer...
  34. doi request reprint Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer
    Andrew J Stephenson
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 75:382-6. 2010
    ..The aggregate LN metastasis diameter (ALNMD) may better reflect the burden of metastatic disease and improve the ability to predict recurrence-free (RFS) and overall survival (OS)...
  35. ncbi request reprint Management of clinical stage I nonseminomatous germ cell testicular cancer
    Toni K Choueiri
    Department of Solid Tumor Oncology, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    Urol Clin North Am 34:137-48; abstract viii. 2007
    ..For patients at high risk for relapse and who are not candidates for surveillance, we believe the evidence supports RPLND over primary chemotherapy...
  36. ncbi request reprint Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:2781-8. 2005
    ..Since 1999, our criteria have excluded patients with persistent postorchiectomy elevation of serum tumor markers (STM) or clinical stage (CS) IIB disease from RPLND...
  37. doi request reprint Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder
    Anil A Thomas
    Glickman Urological and Kidney Institute, The Cleveland Clinic, Cleveland, OH 44195, USA
    Hum Pathol 40:108-16. 2009
    ....
  38. ncbi request reprint Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy
    Matthew N Simmons
    Glickman Urological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue A100, Cleveland, OH 44195, USA
    Eur Urol 51:1175-84. 2007
    ..While a rising PSA level universally antedates metastatic progression and prostate cancer-specific mortality (PCSM), it is not a surrogate for these endpoints. Thus, the management of patients with BCR is controversial...
  39. doi request reprint Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy
    Brian R Lane
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Urology 72:1240-5. 2008
    ..The results from 3 retrospective studies have suggested that low pretreatment testosterone is an independent predictor of adverse pathologic features in patients with localized prostate cancer...
  40. doi request reprint Prostate cancer volume at biopsy predicts clinically significant upgrading
    Fei Dong
    Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
    J Urol 179:896-900; discussion 900. 2008
    ..We identified clinical and pathological parameters that predict pathological upgrading in this population...
  41. doi request reprint Comparative outcomes of laparoscopic and open adrenalectomy for adrenocortical carcinoma: single, high-volume center experience
    Maria C Mir
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    Ann Surg Oncol 20:1456-61. 2013
    ..Previous studies reported increased recurrence rates associated with laparoscopic adrenalectomy (LA). We evaluated a single-center experience of LA versus open adrenalectomy (OA) for the management of ACC...
  42. ncbi request reprint Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:8198-203. 2005
    ..Salvage RP may favorably alter the natural history of biochemical recurrence after radiation therapy, but it must be instituted early in the course of recurrent disease to be effective...
  43. doi request reprint Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors
    Carvell T Nguyen
    Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Q10, Cleveland, OH 44195, USA
    Hematol Oncol Clin North Am 25:593-604, ix. 2011
    ..This article reviews the indications, technique, and outcomes of PC-RPLND in the management of advanced GCT...
  44. doi request reprint American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors
    Timothy D Gilligan
    Taussig Cancer Institute and the Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    J Clin Oncol 28:3388-404. 2010
    ..To provide recommendations on appropriate uses for serum markers of germ cell tumors (GCTs)...
  45. ncbi request reprint Management of patients with low-stage nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Treat Options Oncol 6:367-77. 2005
    ....
  46. ncbi request reprint Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy
    Timothy A Masterson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 66:623-6. 2005
    ..To analyze the feasibility of neurovascular bundle (NVB) preservation and peripheral nerve grafting during salvage radical prostatectomy (RP) for radiorecurrent prostate cancer and analyze their effect on the recovery of potency...
  47. doi request reprint Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice
    Fei Dong
    School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
    J Urol 180:150-4; discussion 154. 2008
    ..In patients referred for biopsy following community screening we validated the Kattan and Steyerberg nomograms for predicting indolent disease in a contemporary urological practice...
  48. doi request reprint Surgical resection of renal cell carcinoma after targeted therapy
    Anil A Thomas
    Glickman Urological and Kidney Institute, Cleveland, Ohio 44195, USA
    J Urol 182:881-6. 2009
    ..The integration of targeted therapy and surgery requires careful consideration due to the potential for increased perioperative morbidity...
  49. doi request reprint Bacillus Calmette-Guérin osteomyelitis mimicking spinal metastasis from urothelial cell carcinoma of the bladder
    Amit R Patel
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    Eur Urol 58:934-7. 2010
    ..The patient was treated with isoniazid, rifampin, ethambutol, and pyrazinamide...
  50. ncbi request reprint Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    JAMA 291:1325-32. 2004
    ..Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highest risk of metastatic disease progression...
  51. pmc Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 104:290-8. 2005
    ..Gene expression profiling of prostate carcinoma offers an alternative means to distinguish aggressive tumor biology and may improve the accuracy of outcome prediction for patients with prostate carcinoma treated by radical prostatectomy...
  52. ncbi request reprint Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 176:1996-9; discussion 1999. 2006
    ..We reviewed our experience with adjunctive nephrectomy to assess the impact on cancer control and renal function...
  53. ncbi request reprint Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 172:2239-43. 2004
    ..We report the morbidity associated with salvage RP in 100 consecutive patients...
  54. doi request reprint Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart
    Jennifer Ko
    Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Prostate 73:897-903. 2013
    ..Consensus on prostate cancer (PCA) treatment in older men is currently lacking. We evaluated clinicopathological and oncological outcomes in patients >70-year-old treated with radical prostatectomy (RP)...
  55. doi request reprint Clinicians versus nomogram: predicting future technetium-99m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Urology 81:956-61. 2013
    ..To compare the ability of clinicians vs a nomogram at predicting future bone scan positivity in patients with prostate cancer...
  56. doi request reprint The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatment
    Jay P Ciezki
    Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 75:467-71. 2010
    ..To assess the relationship between prostate-specific antigen (PSA) testing frequency and biochemical failure (bF) and clinical failure (cF)...
  57. ncbi request reprint The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Urol 1:90-6. 2004
    ..To be successful, salvage EBRT should be administered at the earliest evidence of recurrent disease, once a rising PSA trend as been confirmed...
  58. doi request reprint Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi
    Vairavan S Subramanian
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 74:154-9. 2009
    ..Preoperative embolization has been used as an adjunctive procedure to facilitate surgical resection of complex renal tumors...
  59. doi request reprint Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?
    Amit R Patel
    Center for Urologic Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 0001, USA
    Nat Rev Urol 8:385-92. 2011
    ....
  60. doi request reprint Are nomograms needed in the management of bladder cancer?
    Carvell T Nguyen
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Urol Oncol 28:102-7. 2010
    ..Although their use has become more widespread, bladder cancer nomograms remain a relatively nascent field of study, and further development of novel nomograms that can account for all clinical stages of bladder cancer is needed...
  61. ncbi request reprint The role of retroperitoneal lymph node dissection in the management of testicular cancer
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Urol Oncol 22:225-33; discussion 234-5. 2004
    ..This article reviews the role of RPLND in the management of patients with NSGCT at all stages and its role in advanced seminoma...
  62. doi request reprint Multidisciplinary management of patients with localized bladder cancer
    Kiranpreet K Khurana
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Surg Oncol Clin N Am 22:357-73. 2013
    ..Bladder-preservation protocols involving a visibly complete transurethral resection followed by chemoradiation may be a feasible option for select patients...
  63. doi request reprint When serial prostate biopsy is recommended: most cancers detected are clinically insignificant
    Osama M Zaytoun
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    BJU Int 110:987-92. 2012
    ..Moreover, it addressed the impact of detecting premalignant lesions on further detection of cancer in serial biopsy...
  64. doi request reprint Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma
    Katherine E Watts
    Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 80:361-6. 2012
    ..To investigate the clinicopathologic and immunohistochemical features associated with invasive low-grade papillary urothelial carcinoma (LGPUC), an uncommon entity not previously described in published studies...
  65. ncbi request reprint Screening for urologic malignancies in primary care: pros, cons, and recommendations
    Andrew J Stephenson
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 74:S6-14. 2007
    ....
  66. ncbi request reprint Impact of unnecessary exploratory laparotomy on the treatment of patients with metastatic germ cell tumor
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:1474-7. 2004
    ..In a cohort of patients who underwent exploratory laparotomy for unsuspected metastatic GCT we determined the impact of this surgery on morbidity, therapeutic delay and cancer therapy...
  67. ncbi request reprint Complications of radical and partial nephrectomy in a large contemporary cohort
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Cancer Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:130-4. 2004
    ..We reviewed the early complications of radical nephrectomy (RN) and partial nephrectomy (PN) in a large contemporary cohort using a standardized complication grading scale...
  68. doi request reprint Re: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400)
    Andrew J Stephenson
    Urology 72:719-20. 2008
  69. ncbi request reprint Variations in PSA doubling time in patients with prostate cancer on "watchful waiting": value of short-term PSADT determinations
    Phillip L Ross
    Division of Urology, McGill University, Montreal, Quebec, Canada
    Urology 64:323-8. 2004
    ..Our aim was to determine the correlation between short-term PSADT measurements and long-term PSADT among men with prostate cancer on observation...
  70. ncbi request reprint Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy
    Andrew J Stephenson
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Treat Options Oncol 5:357-65. 2004
    ..A long-term cure is possible for patients with locally recurrent prostate cancer after radiation therapy. Local salvage therapy must be instituted early to be successful in the course of progressive disease...
  71. ncbi request reprint Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy
    Andrew J Stephenson
    Division of Urology, McGill University, Montreal, Quebec, Canada
    J Urol 172:58-62. 2004
    ..We characterized relapse patterns in patients with sporadic renal cell carcinoma (RCC) following radical and partial nephrectomy, and developed surveillance guidelines...
  72. ncbi request reprint Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer
    Andrew J Stephenson
    Department of Surgery Urology, McGill University, Montreal, Ontario, Canada
    Urology 59:652-6. 2002
    ..To evaluate the prostate-specific antigen (PSA) changes and the ability of PSA doubling time (PSADT) to predict disease progression in untreated patients with clinically localized prostate cancer...
  73. doi request reprint Systems pathology and predicting outcome after radical prostatectomy
    Eric A Klein
    J Clin Oncol 26:3916-7. 2008
  74. pmc Gene expression profiling predicts clinical outcome of prostate cancer
    Gennadi V Glinsky
    Sidney Kimmel Cancer Center, San Diego, California 92121, USA
    J Clin Invest 113:913-23. 2004
    ....